# Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

> **NCT00553865** · PHASE2 · COMPLETED · sponsor: **Jeil Pharmaceutical Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** OJP-2028

## Key facts

- **NCT ID:** NCT00553865
- **Lead sponsor:** Jeil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553865, "Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00553865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*